REVELATION BIOSCIENCES, INC. Proceeds from Issuance of Private Placement
REVELATION BIOSCIENCES, INC. (REVB) reported Proceeds from Issuance of Private Placement of $3.23 million for the 12-month period ending 2020-12-31, per its 10-K filed 2022-04-15.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfPrivatePlacement · last filed 2022-04-15
- REVELATION BIOSCIENCES, INC. proceeds from issuance of private placement for the quarter ending 2020-12-31 was $83.45K.
- REVELATION BIOSCIENCES, INC. proceeds from issuance of private placement for fiscal 2020 was $3.23M.
| Period end | Proceeds from Issuance of Private Placement 3 month | Proceeds from Issuance of Private Placement 9 month | Proceeds from Issuance of Private Placement 12 month |
|---|---|---|---|
| 2020-12-31 | $83.45K derived: 10-K 12 month − 10-Q 9 month · filed 2022-04-15 | $3.23M 10-K · filed 2022-04-15 | |
| 2020-09-30 | $3.15M 10-Q · filed 2021-10-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| Onconetix, Inc. (ONCO) | United States | $0.004B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |